Dr. Mark Kurt Nawaane Urges Shift in US Health Aid Toward Essential Medicines and Regulatory Sovereignty

Dr. Mark Kurt Nawaane, the Chairman of Parliament’s Select Committee on Health, has raised significant concerns regarding the structure of future health assistance from the United States, calling for a pivot toward direct medication procurement. Speaking on the urgent needs of the Ghanaian health sector, Dr. Nawaane emphasized that the country’s primary requirement is financial support to purchase essential drugs rather than the heavy emphasis on capacity-building programs currently being proposed. He argued that while training and institutional meetings have their place, they do not address the immediate, life-threatening shortages of medicines for patients suffering from tuberculosis (TB), HIV, and malaria. The Chairman highlighted a stark disparity between projected donor spending and Ghana's actual pharmaceutical needs. With an estimated $74 million funding gap for essential medicines, Dr. Nawaane questioned the relevance of proposed allocations of $82.5 million for capacity-building in 2025 and a further $53 million in 2026. According to the lawmaker, these resources would be far more effectively utilized if they were redirected to closing the medication gap, ensuring that patients have consistent access to the treatments they need to survive and manage chronic conditions. Beyond the financial allocation, Dr. Nawaane also cautioned against clauses in a proposed US-Ghana health compact that could potentially undermine the regulatory authority of the Food and Drugs Authority (FDA). He expressed concern that the compact might limit the FDA’s power to inspect and verify the safety of medical products entering the country in exchange for approximately $100 million in aid. Highlighting the FDA's hard-won achievement of Maturity Level 3 under World Health Organization (WHO) classification, he insisted that Ghana should not compromise its high regulatory standards or public health safety for foreign financial support. In his concluding remarks, Dr. Nawaane called for a fundamental restructuring of health partnerships to ensure they align more closely with Ghana’s national priorities. He urged that future agreements must respect the sovereignty of local regulatory bodies and prioritize the tangible procurement of health commodities over administrative training sessions. As the government continues to navigate international health collaborations, the focus remains on securing a system that provides both the necessary drugs for the vulnerable and the independent oversight required to ensure those drugs meet safety standards.